FORA Capital LLC purchased a new position in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 1,970 shares of the semiconductor company's stock, valued at approximately $222,000.
Several other large investors have also made changes to their positions in the company. Invesco Ltd. boosted its position in shares of Silicon Laboratories by 42.7% during the 1st quarter. Invesco Ltd. now owns 849,730 shares of the semiconductor company's stock worth $95,654,000 after acquiring an additional 254,348 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Silicon Laboratories by 48.7% during the 1st quarter. American Century Companies Inc. now owns 510,178 shares of the semiconductor company's stock worth $57,431,000 after acquiring an additional 167,047 shares in the last quarter. Northern Trust Corp boosted its position in shares of Silicon Laboratories by 12.5% during the 4th quarter. Northern Trust Corp now owns 415,007 shares of the semiconductor company's stock worth $51,552,000 after acquiring an additional 46,109 shares in the last quarter. Westfield Capital Management Co. LP acquired a new stake in shares of Silicon Laboratories during the 1st quarter worth approximately $37,249,000. Finally, Nuveen Asset Management LLC boosted its position in shares of Silicon Laboratories by 5.1% during the 4th quarter. Nuveen Asset Management LLC now owns 289,369 shares of the semiconductor company's stock worth $35,945,000 after acquiring an additional 14,117 shares in the last quarter.
Analyst Upgrades and Downgrades
Several brokerages recently commented on SLAB. Morgan Stanley dropped their price objective on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research note on Wednesday, August 6th. Barclays increased their price objective on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 5th. Benchmark reissued a "buy" rating and issued a $160.00 price objective on shares of Silicon Laboratories in a research note on Tuesday, May 27th. Needham & Company LLC reissued a "buy" rating and issued a $150.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, May 14th. Finally, Susquehanna increased their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research note on Tuesday, July 22nd. Five investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.
Get Our Latest Analysis on Silicon Laboratories
Silicon Laboratories Trading Down 2.3%
NASDAQ:SLAB traded down $3.10 during trading hours on Monday, hitting $134.35. 250,212 shares of the company were exchanged, compared to its average volume of 373,039. The stock has a market capitalization of $4.41 billion, a price-to-earnings ratio of -41.72 and a beta of 1.52. Silicon Laboratories, Inc. has a one year low of $82.82 and a one year high of $160.00. The company has a fifty day simple moving average of $138.68 and a 200 day simple moving average of $127.25.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The business had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. During the same period last year, the company earned ($0.56) EPS. Silicon Laboratories's revenue for the quarter was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities research analysts predict that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.
Insider Buying and Selling at Silicon Laboratories
In other news, SVP Brandon Tolany sold 8,000 shares of Silicon Laboratories stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $145.23, for a total value of $1,161,840.00. Following the completion of the transaction, the senior vice president directly owned 62,328 shares of the company's stock, valued at approximately $9,051,895.44. This trade represents a 11.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.60% of the company's stock.
About Silicon Laboratories
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report